Clinical trial
Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in…
NCT00005998 · Masonic Cancer Center, University of Minnesota, Other · Withdrawn
Key facts
| NCT number | NCT00005998 |
|---|---|
| Title | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease |
| Official title | Autologous Transplantation for Non-Hodgkin's Lymphoma and Hodgkin's Disease Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Mobilization Using Hematopoietic Cytokines Plus Chemotherapy |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | carmustine, cyclophosphamide, cytarabine, dexamethasone, etoposide, filgrastim, mitoxantrone hydrochloride, retrovirus vector LN, in vitro-treated peripheral blood stem cell transplantation, peripheral blood stem cell transplantation and 1 more |
| Enrollment | 0 |
| Start date | Jan 1, 2000 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | Oct 8, 2003 |
| Last update posted | Nov 29, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: